Style | Citing Format |
---|---|
MLA | Molaahmadi MR, et al.. "Lipid Nanocapsules for Imatinib Delivery: Design, Optimization and Evaluation of Anticancer Activity Against Melanoma Cell Line." Iranian Journal of Pharmaceutical Research, vol. 18, no. 4, 2019, pp. 1676-1693. |
APA | Molaahmadi MR, Varshosaz J, Taymouri S, Akbari V (2019). Lipid Nanocapsules for Imatinib Delivery: Design, Optimization and Evaluation of Anticancer Activity Against Melanoma Cell Line. Iranian Journal of Pharmaceutical Research, 18(4), 1676-1693. |
Chicago | Molaahmadi MR, Varshosaz J, Taymouri S, Akbari V. "Lipid Nanocapsules for Imatinib Delivery: Design, Optimization and Evaluation of Anticancer Activity Against Melanoma Cell Line." Iranian Journal of Pharmaceutical Research 18, no. 4 (2019): 1676-1693. |
Harvard | Molaahmadi MR et al. (2019) 'Lipid Nanocapsules for Imatinib Delivery: Design, Optimization and Evaluation of Anticancer Activity Against Melanoma Cell Line', Iranian Journal of Pharmaceutical Research, 18(4), pp. 1676-1693. |
Vancouver | Molaahmadi MR, Varshosaz J, Taymouri S, Akbari V. Lipid Nanocapsules for Imatinib Delivery: Design, Optimization and Evaluation of Anticancer Activity Against Melanoma Cell Line. Iranian Journal of Pharmaceutical Research. 2019;18(4):1676-1693. |
BibTex | @article{ author = {Molaahmadi MR and Varshosaz J and Taymouri S and Akbari V}, title = {Lipid Nanocapsules for Imatinib Delivery: Design, Optimization and Evaluation of Anticancer Activity Against Melanoma Cell Line}, journal = {Iranian Journal of Pharmaceutical Research}, volume = {18}, number = {4}, pages = {1676-1693}, year = {2019} } |
RIS | TY - JOUR AU - Molaahmadi MR AU - Varshosaz J AU - Taymouri S AU - Akbari V TI - Lipid Nanocapsules for Imatinib Delivery: Design, Optimization and Evaluation of Anticancer Activity Against Melanoma Cell Line JO - Iranian Journal of Pharmaceutical Research VL - 18 IS - 4 SP - 1676 EP - 1693 PY - 2019 ER - |